Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

NCT04008771 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

DEVICE: SeeQ CdSe 655 ALT

Sponsor

2C Tech Corp